Valeo Pharma Inc.

Valeo Pharma Inc.

VPHIF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$9.87K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Valeo Pharma Inc.Valeo Pharma Inc.0-51%--1.1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$9,866.00
Enterprise Value$62.92 Million
Earnings per Share$-0.32
Beta0.81
Outstanding Shares98,675,427

Return

Return on Equity50.96%ROE
Return on Assets-99.77%
Return on Invested Capital49.38%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue1.18
Enterprise Value to EBIT-3.38
Enterprise Value to Net Income-2
Total Debt to Enterprise1.11
Debt to Equity-1.11Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
September 30, 2026
EPS Estimate
-$0.02
Consensus analyst estimate
Revenue Estimate
$3.83 M
Consensus analyst estimate

Next Earnings Call

Expected Date
December 30, 2026
EPS Estimate
-$0.02
Consensus analyst estimate
Revenue Estimate
$3.82 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Valeo Pharma Inc.

70 employees
CEO: Kyle Steiger

Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to sourcing, licensing, and selling a variety of medicinal products, with a primary emphasis on respiratory, specialized, and hospital-grade generic drugs. Its exten...